Table 2.
Description of the study visits
| Visit | Day | Description |
|---|---|---|
| Phase I: Screening and inclusion in the study (intervention and control groups) | ||
| V0 | Day 1 | Frailty-screening |
| V1 | Day 1/2 | Inclusion into study |
| V2 | Day 1/2 | Baseline assessment, followed by randomization |
| Phase II: Shared decision-making (intervention group only) | ||
| V3 | V1/V1 + 1–5 days | SDM conference |
| Phase III: Prehabilitation (intervention group only) | ||
| V4 | 22–25 days before surgery | Start prehabilitation |
| V5 | V4 + 21 days | End prehabilitation |
| Phase IV: Follow-up (intervention and control groups) | ||
| V6 | 7–14 days post-surgery | Discharge from hospital |
| V7, V8 | 1/2 months post-surgery | Telemedical/telephone interview |
| V9 | 3 months post-surgery | Follow-up at 3 months (telemedical/telephone interview or home visit) |
| V10–V17 | 4–11 post-surgery | Telemedical/telephone interview |
| V18 | 12 months post-surgery | Follow-up at 12 months (home visit) |